X-129558664-T-G

Variant summary

Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP4_StrongBP6BP7BS2

The NM_000276.4(OCRL):​c.471T>G​(p.Ser157Ser) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000165 in 1,210,540 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 5 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. S157S) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.000018 ( 0 hom., 0 hem., cov: 23)
Exomes 𝑓: 0.000016 ( 0 hom. 5 hem. )

Consequence

OCRL
NM_000276.4 synonymous

Scores

2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:2

Conservation

PhyloP100: -0.946

Publications

1 publications found
Variant links:
Genes affected
OCRL (HGNC:8108): (OCRL inositol polyphosphate-5-phosphatase) This gene encodes an inositol polyphosphate 5-phosphatase. This protein is involved in regulating membrane trafficking and is located in numerous subcellular locations including the trans-Golgi network, clathrin-coated vesicles and, endosomes and the plasma membrane. This protein may also play a role in primary cilium formation. Mutations in this gene cause oculocerebrorenal syndrome of Lowe and also Dent disease. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Jan 2016]
OCRL Gene-Disease associations (from GenCC):
  • Dent disease type 2
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, G2P, Laboratory for Molecular Medicine, Orphanet, Labcorp Genetics (formerly Invitae)
  • oculocerebrorenal syndrome
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P, ClinGen, Orphanet, Laboratory for Molecular Medicine

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -10 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.79).
BP6
Variant X-129558664-T-G is Benign according to our data. Variant chrX-129558664-T-G is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 211782.
BP7
Synonymous conserved (PhyloP=-0.946 with no splicing effect.
BS2
High Hemizygotes in GnomAdExome4 at 5 XL gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000276.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
OCRL
NM_000276.4
MANE Select
c.471T>Gp.Ser157Ser
synonymous
Exon 7 of 24NP_000267.2
OCRL
NM_001318784.2
c.474T>Gp.Ser158Ser
synonymous
Exon 7 of 24NP_001305713.1
OCRL
NM_001587.4
c.471T>Gp.Ser157Ser
synonymous
Exon 7 of 23NP_001578.2

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
OCRL
ENST00000371113.9
TSL:1 MANE Select
c.471T>Gp.Ser157Ser
synonymous
Exon 7 of 24ENSP00000360154.4
OCRL
ENST00000357121.5
TSL:1
c.471T>Gp.Ser157Ser
synonymous
Exon 7 of 23ENSP00000349635.5
OCRL
ENST00000486673.1
TSL:5
n.713T>G
non_coding_transcript_exon
Exon 7 of 8

Frequencies

GnomAD3 genomes
AF:
0.0000177
AC:
2
AN:
112807
Hom.:
0
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000187
Gnomad OTH
AF:
0.000656
GnomAD2 exomes
AF:
0.0000328
AC:
6
AN:
182956
AF XY:
0.0000148
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0000625
Gnomad NFE exome
AF:
0.0000489
Gnomad OTH exome
AF:
0.000223
GnomAD4 exome
AF:
0.0000164
AC:
18
AN:
1097733
Hom.:
0
Cov.:
30
AF XY:
0.0000138
AC XY:
5
AN XY:
363107
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
26395
American (AMR)
AF:
0.00
AC:
0
AN:
35201
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19380
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30201
South Asian (SAS)
AF:
0.00
AC:
0
AN:
54109
European-Finnish (FIN)
AF:
0.0000247
AC:
1
AN:
40517
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4118
European-Non Finnish (NFE)
AF:
0.0000202
AC:
17
AN:
841730
Other (OTH)
AF:
0.00
AC:
0
AN:
46082
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.452
Heterozygous variant carriers
0
2
4
5
7
9
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000177
AC:
2
AN:
112807
Hom.:
0
Cov.:
23
AF XY:
0.00
AC XY:
0
AN XY:
34941
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
31009
American (AMR)
AF:
0.00
AC:
0
AN:
10694
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2648
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3616
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2774
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6227
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
239
European-Non Finnish (NFE)
AF:
0.0000187
AC:
1
AN:
53387
Other (OTH)
AF:
0.000656
AC:
1
AN:
1524
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.550
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.00000756

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not specified Uncertain:1
Mar 23, 2015
Genetic Services Laboratory, University of Chicago
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Lowe syndrome Benign:1
Nov 06, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not provided Benign:1
Jan 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

OCRL: BP4, BP7

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.79
CADD
Benign
6.3
DANN
Benign
0.67
PhyloP100
-0.95

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs747396791; hg19: chrX-128692641; API